Dextroamphetamine and Pramipexole Combination for Treatment-Resistant Unipolar Depression

Overview

Journal Psychiatr Ann

Specialty Social Sciences

Date 2016 Sep 27

PMID 27667864

Authors

Maju Mathew Koola

Jan Fawcett

Affiliations

Soon will be listed here.

References

Argyropoulos S, Nutt D . Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?. J Psychopharmacol. 2013; 27(10):869-77. DOI: 10.1177/0269881113494104. View

Candy M, Jones L, Williams R, Tookman A, King M . Psychostimulants for depression. Cochrane Database Syst Rev. 2008; (2):CD006722. DOI: 10.1002/14651858.CD006722.pub2. View

Kelleher J, Centorrino F, Huxley N, Bates J, Drake J, Egli S . Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur Neuropsychopharmacol. 2011; 22(6):415-8. DOI: 10.1016/j.euroneuro.2011.10.002. View

Dunlop B, Nemeroff C . The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007; 64(3):327-37. DOI: 10.1001/archpsyc.64.3.327. View

Koola M, Fawcett J . A Case of Electroconvulsive Therapy-Resistant Depression Responding to Multiple Dopaminergic Medications. Prim Care Companion CNS Disord. 2015; 17(2). PMC: 4560184. DOI: 10.4088/PCC.14l01745. View

Thase M, Rush A . When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997; 58 Suppl 13:23-9. View

Aiken C . Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry. 2007; 68(8):1230-6. View

Salamone J, Pardo M, Yohn S, Lopez-Cruz L, SanMiguel N, Correa M . Mesolimbic Dopamine and the Regulation of Motivated Behavior. Curr Top Behav Neurosci. 2015; 27:231-57. DOI: 10.1007/7854_2015_383. View

Conway C, Chibnall J, Cumming P, Mintun M, Gebara M, Perantie D . Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study. Psychiatry Res. 2014; 221(3):231-9. PMC: 3982608. DOI: 10.1016/j.pscychresns.2014.01.003. View

10.

de Kwaasteniet B, Pinto C, Ruhe H, Ruhe E, van Wingen G, Booij J . Striatal dopamine D2/3 receptor availability in treatment resistant depression. PLoS One. 2014; 9(11):e113612. PMC: 4239080. DOI: 10.1371/journal.pone.0113612. View

11.

Lapinsky D, Aggarwal S, Nolan T, Surratt C, Lever J, Acharya R . (±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban). Bioorg Med Chem Lett. 2011; 22(1):523-6. PMC: 3249008. DOI: 10.1016/j.bmcl.2011.10.086. View